Latest news
Loading news…
Crinetics Pharmaceuticals discovers, develops, and commercializes medicines for endocrine diseases and endocrine-related tumors.
Crinetics Pharmaceuticals was acquired by Vertex Pharmaceuticals in 2026 for $10B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Investments
1
Monthly Visits
Available in Pro Contacts
283
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Investor Activity
- Investments
- 1
- Portfolio orgs
- 1
Company Info
- Org types
- company, investor
- HQ
- San Diego, California, United States
Investments by Crinetics Pharmaceuticals
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Crinetics Pharmaceuticals
Executive Director of Government Affairs and Patient Advocacy
Chief Medical Officer
Vice President, Biology
Co-Founder & Vice President, Chemistry
Chief Business Officer
Chief Development Officer
Founder & Chief Executive Officer
Senior Vice President - Medical Affairs
283
professional contacts at Crinetics Pharmaceuticals
Contact execs at Crinetics Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Crinetics Pharmaceuticals
Loading news…
FAQs about Crinetics Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.